Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing

Br J Cancer. 1995 Apr;71(4):801-7. doi: 10.1038/bjc.1995.155.

Abstract

A cytotoxicity assay was used to study the action of bacillus Calmette-Guerin (BCG) and cytokines on four human bladder cancer cell lines. Monocytes and lymphocytes from peripheral blood were incubated with or without BCG or cytokines for 24 h, after which [3H]thymidine-labelled target cells were added and the 72 h percentage specific release determined. BCG had a direct cytotoxic effect against tumour cells and significantly enhanced monocyte/macrophage and enhanced lymphocyte cytotoxicity against one cell line (UCRU-BL-17). Supernatants (SNs) from BCG-activated monocytes/macrophages and lymphocytes increased the percentage specific release of [3H]thymidine from UCRU-BL-17 cells. Interferon alpha (IFN-alpha) and interleukin 2 (IL-2) were cytotoxic towards UCRU-BL-17. No synergy occurred between BCG and cytokines at the concentrations tested. The results suggest that BCG is superior to IFN-alpha, interferon gamma (IFN-gamma) and IL-2 in enhancing cell-mediated cytotoxicity.

Publication types

  • Comparative Study

MeSH terms

  • Carcinoma, Transitional Cell / immunology*
  • Carcinoma, Transitional Cell / pathology
  • Cell Line
  • Cytotoxicity, Immunologic
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / pharmacology
  • Interferon-gamma / pharmacology
  • Interleukin-2 / pharmacology
  • Lymphocytes / immunology*
  • Macrophages / immunology
  • Monocytes / immunology*
  • Mycobacterium bovis / immunology*
  • Recombinant Proteins / pharmacology
  • T-Lymphocytes / immunology
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / immunology*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Interleukin-2
  • Recombinant Proteins
  • Interferon-gamma